HI SB738 | 2022 | Regular Session

Note: Carry Over of previous SB738

Status

Spectrum: Partisan Bill (Democrat 4-0)
Status: Introduced on January 22 2021 - 25% progression, died in committee
Action: 2021-12-10 - Carried over to 2022 Regular Session.
Pending: Senate Judiciary Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Removes psilocybin and psilocyn from the list of Schedule I substances. Requires the Department of Health to establish designated treatment centers for the therapeutic administration of psilocybin and psilocyn. Establishes a review panel to review and assess the effects of this measure.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Relating To Schedule I Substances.

Sponsors


History

DateChamberAction
2021-12-10 Carried over to 2022 Regular Session.
2021-02-23SenateThe committee on JDC deferred the measure.
2021-02-19SenateThe committee(s) on JDC deferred the measure until 02-23-21 9:40AM; Via Videoconference.
2021-02-16SenateThe committee(s) on JDC has scheduled a public hearing on 02-19-21 9:30AM; Via Videoconference.
2021-02-08SenateRe-Referred to JDC.
2021-01-27SenateReferred to PSM, JDC.
2021-01-25SenatePassed First Reading.
2021-01-22SenateIntroduced.

Same As/Similar To

SB738 (Carry Over) 2021-02-23 - The committee on JDC deferred the measure.

Subjects


Hawaii State Sources


Bill Comments

feedback